WHAT WE OFFER

Clinical development services for decisions that must hold

From pivotal design and trial rescue to investor diligence, Medical Affairs and NECTAR-enabled execution, MB&P helps clinical programs become regulator-credible, payer-relevant and execution-ready.

Service gateway

Choose the right mandate

Each entry point connects a defined decision or execution problem to senior ownership, concrete outputs and the appropriate delivery model.

Seven MB&P service entry points connected to one clinical-development system without fragmented accountability.

Senior ownership

Accountable CMO-level judgment for clinical strategy, board alignment and execution governance.

Design

Evidence architecture, endpoint logic, estimands, feasibility and pivotal readiness.

Recovery

Restore signal integrity, feasibility realism and execution control before decision value is lost.

Evidence

Align approval, payer relevance and evidence generation before requirements diverge.

Capital

Clinical risk maps, value gates and fundable development plans that withstand technical diligence.

Scientific authority

Connect scientific narrative, evidence strategy, external insight and adoption credibility.

Execution

Governed global execution through Verum and qualified local reach through NECTAR.

Problems we solve

Recognize the failure mode

The development thesis is unclear

The program lacks one testable logic connecting mechanism, population, evidence and future value.

Pivotal choices do not align

Endpoints, estimands, comparator, duration, feasibility and payer relevance pull in different directions.

The trial is losing control

Recruitment, site behavior, vendor performance, quality signals or governance threaten the readout.

Senior medical ownership is missing

Critical decisions are diffused across functions, advisors and vendors without one accountable owner.

The asset is difficult to finance

Clinical risk, use of proceeds and value-inflection milestones are not explicit enough for diligence.

Evidence does not translate

Medical Affairs, HEOR, RWE and market access remain downstream from development strategy.

Engagement models

Match the structure to the mandate

Hourly, on-demand senior judgment for a defined decision, document or risk. Maximum flexibility with no ongoing capacity commitment.

Fixed or capped around a clearly defined output such as a risk map, development plan, protocol review or diligence package.

Phase- or milestone-based delivery for redesign, rescue, evidence strategy or governance implementation, with spend tied to defined work packages and decision gates.

Monthly retainer or fractional leadership with reserved senior capacity, defined decision rights, cadence and escalation. Greater duration and commitment reduce the effective unit cost.

One-stop operating model

Use one entry point or connect the full development path

The seven services are entry points, not silos. A mandate can begin with one decision and expand only where the interfaces create material risk. Clinical strategy, regulatory and payer evidence, fundraising readiness, Medical Affairs and operational execution remain connected through one governance logic.

  • One accountable clinical architecture across functions
  • Fundraising and partnering readiness embedded in the development path
  • Verum as the sponsor-facing execution spine
  • NECTAR local depth where it improves speed, access or regulatory fluency

A decision-grade next step

Start with the problem, not a generic scope.

We will identify the right level of ownership and the shortest credible path to a decision.